Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 315

1.

Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.

Bousquet JJ, Schünemann HJ, Togias A, Erhola M, Hellings PW, Zuberbier T, Agache I, Ansotegui IJ, Anto JM, Bachert C, Becker S, Bedolla-Barajas M, Bewick M, Bosnic-Anticevich S, Bosse I, Boulet LP, Bourrez JM, Brusselle G, Chavannes N, Costa E, Cruz AA, Czarlewski W, Fokkens WJ, Fonseca JA, Gaga M, Haahtela T, Illario M, Klimek L, Kuna P, Kvedariene V, Le LTT, Larenas-Linnemann D, Laune D, Lourenço OM, Menditto E, Mullol J, Okamoto Y, Papadopoulos N, Pham-Thi N, Picard R, Pinnock H, Roche N, Roller-Wirnsberger RE, Rolland C, Samolinski B, Sheikh A, Toppila-Salmi S, Tsiligianni I, Valiulis A, Valovirta E, Vasankari T, Ventura MT, Walker S, Williams S, Akdis CA, Annesi-Maesano I, Arnavielhe S, Basagana X, Bateman E, Bedbrook A, Bennoor KS, Benveniste S, Bergmann KC, Bialek S, Billo N, Bindslev-Jensen C, Bjermer L, Blain H, Bonini M, Bonniaud P, Bouchard J, Briedis V, Brightling CE, Brozek J, Buhl R, Buonaiuto R, Canonica GW, Cardona V, Carriazo AM, Carr W, Cartier C, Casale T, Cecchi L, Cepeda Sarabia AM, Chkhartishvili E, Chu DK, Cingi C, Colgan E, de Sousa JC, Courbis AL, Custovic A, Cvetkosvki B, D'Amato G, da Silva J, Dantas C, Dokic D, Dauvilliers Y, Dedeu A, De Feo G, Devillier P, Di Capua S, Dykewickz M, Dubakiene R, Ebisawa M, El-Gamal Y, Eller E, Emuzyte R, Farrell J, Fink-Wagner A, Fiocchi A, Fontaine JF, Gemicioğlu B, Schmid-Grendelmeir P, Gamkrelidze A, Garcia-Aymerich J, Gomez M, González Diaz S, Gotua M, Guldemond NA, Guzmán MA, Hajjam J, O'B Hourihane J, Humbert M, Iaccarino G, Ierodiakonou D, Illario M, Ivancevich JC, Joos G, Jung KS, Jutel M, Kaidashev I, Kalayci O, Kardas P, Keil T, Khaitov M, Khaltaev N, Kleine-Tebbe J, Kowalski ML, Kritikos V, Kull I, Leonardini L, Lieberman P, Lipworth B, Lodrup Carlsen KC, Loureiro CC, Louis R, Mair A, Marien G, Mahboub B, Malva J, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Maspero JF, Mathieu-Dupas E, Matricardi PM, Melén E, Melo-Gomes E, Meltzer EO, Menditto E, Mercier J, Miculinic N, Mihaltan F, Milenkovic B, Moda G, Mogica-Martinez MD, Mohammad Y, Montefort S, Monti R, Morais-Almeida M, Mösges R, Münter L, Muraro A, Murray R, Naclerio R, Napoli L, Namazova-Baranova L, Neffen H, Nekam K, Neou A, Novellino E, Nyembue D, O'Hehir R, Ohta K, Okubo K, Onorato G, Ouedraogo S, Pali-Schöll I, Palkonen S, Panzner P, Park HS, Pépin JL, Pereira AM, Pfaar O, Paulino E, Phillips J, Picard R, Plavec D, Popov TA, Portejoie F, Price D, Prokopakis EP, Pugin B, Raciborski F, Rajabian-Söderlund R, Reitsma S, Rodo X, Romano A, Rosario N, Rottem M, Ryan D, Salimäki J, Sanchez-Borges MM, Sisul JC, Solé D, Somekh D, Sooronbaev T, Sova M, Spranger O, Stellato C, Stelmach R, Suppli Ulrik C, Thibaudon M, To T, Todo-Bom A, Tomazic PV, Valero AA, Valenta R, Valentin-Rostan M, van der Kleij R, Vandenplas O, Vezzani G, Viart F, Viegi G, Wallace D, Wagenmann M, Wang Y, Waserman S, Wickman M, Williams DM, Wong G, Wroczynski P, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zeng S, Zernotti M, Zhang L, Zhong NS, Zidarn M; ARIA Study Group; MASK Study Group.

Clin Transl Allergy. 2019 Sep 9;9:44. doi: 10.1186/s13601-019-0279-2. eCollection 2019. Review.

2.

Point-of-care biomarkers in asthma management: time to move forward.

Alving K, Diamant Z, Lucas S, Magnussen H, Pavord ID, Piancentini G, Price D, Roche N, Sastre J, Thomas M, Usmani O, Bjermer L; Respiratory Effectiveness Group, Biomarkers Working Group.

Allergy. 2019 Sep 10. doi: 10.1111/all.14045. [Epub ahead of print]

PMID:
31505025
3.

ERS/EAACI Statement on severe exacerbations in asthma in adult: facts, priorities and key research questions.

Bourdin A, Bjermer L, Brightling C, Brusselle G, Chanez P, Chung F, Custovic A, Diamant Z, Diver S, Djukanovic R, Hamerlijnck D, Johnston S, Kanniess F, Papadopoulos N, Papi A, Russell R, Ryan D, Samitas K, Tonia T, Zervas E, Gaga M.

Eur Respir J. 2019 Sep 12. pii: 1900900. doi: 10.1183/13993003.00900-2019. [Epub ahead of print]

PMID:
31467120
4.

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations.

Price DB, Bosnic-Anticevich S, Pavord ID, Roche N, Halpin DMG, Bjermer L, Usmani OS, Brusselle G, Ming SWY, Rastogi S.

Clin Transl Allergy. 2019 Aug 21;9:41. doi: 10.1186/s13601-019-0282-7. eCollection 2019.

5.

Matrisome Properties of Scaffolds Direct Fibroblasts in Idiopathic Pulmonary Fibrosis.

Elowsson Rendin L, Löfdahl A, Åhrman E, Müller C, Notermans T, Michaliková B, Rosmark O, Zhou XH, Dellgren G, Silverborn M, Bjermer L, Malmström A, Larsson-Callerfelt AK, Isaksson H, Malmström J, Westergren-Thorsson G.

Int J Mol Sci. 2019 Aug 17;20(16). pii: E4013. doi: 10.3390/ijms20164013.

6.

Enhanced local production of IL-26 in uncontrolled compared with controlled adult asthma.

Tufvesson E, Jogdand P, Che KF, Levänen B, Erjefält JS, Bjermer L, Lindén A.

J Allergy Clin Immunol. 2019 Jul 6. pii: S0091-6749(19)30902-9. doi: 10.1016/j.jaci.2019.06.035. [Epub ahead of print] No abstract available.

7.
8.

Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma.

Bjermer L, Abbott-Banner K, Newman K.

Pulm Pharmacol Ther. 2019 Jun 14;58:101814. doi: 10.1016/j.pupt.2019.101814. [Epub ahead of print]

PMID:
31202957
9.

Prevalence and Characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap in Routine Primary Care Practices.

Krishnan JA, Nibber A, Chisholm A, Price D, Bateman ED, Bjermer L, van Boven JFM, Brusselle G, Costello RW, Dandurand RJ, Diamant Z, Van Ganse E, Gouder C, van Kampen SC, Kaplan A, Kocks J, Miravitlles M, Niimi A, Pizzichini E, Rhee CK, Soriano JB, Vogelmeier C, Román-Rodriguez M, Carter V, D'Urzo AD, Roche N.

Ann Am Thorac Soc. 2019 Sep;16(9):1143-1150. doi: 10.1513/AnnalsATS.201809-607OC.

PMID:
31162945
10.

Benralizumab for the Prevention of COPD Exacerbations.

Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA and TERRANOVA Study Investigators; GALATHEA Study Investigators; TERRANOVA Study Investigators.

N Engl J Med. 2019 Sep 12;381(11):1023-1034. doi: 10.1056/NEJMoa1905248. Epub 2019 May 20.

PMID:
31112385
11.

EUFOREA consensus on biologics for CRSwNP with or without asthma.

Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, Canonica GW, Deneyer L, Desrosiers M, Diamant Z, Han J, Heffler E, Hopkins C, Jankowski R, Joos G, Knill A, Lee J, Lee SE, Mariën G, Pugin B, Senior B, Seys SF, Hellings PW.

Allergy. 2019 May 15. doi: 10.1111/all.13875. [Epub ahead of print] Review.

PMID:
31090937
12.

The potential role of CD16high CD62Ldim neutrophils in the allergic asthma.

Ekstedt S, Stenberg H, Tufvesson E, Diamant Z, Bjermer L, Kumlien Georén S, Cardell LO.

Allergy. 2019 May 9. doi: 10.1111/all.13861. [Epub ahead of print] No abstract available.

PMID:
31069815
13.

Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018.

Seys SF, Quirce S, Agache I, Akdis CA, Alvaro-Lozano M, Antolín-Amérigo D, Bjermer L, Bobolea I, Bonini M, Bossios A, Brinkman P, Bush A, Calderon M, Canonica W, Chanez P, Couto M, Davila I, Del Giacco S, Del Pozo V, Erjefält JS, Gevaert P, Hagedoorn P, G Heaney L, Heffler E, Hellings PW, Jutel M, Kalayci O, Kurowski MM, Loukides S, Nair P, Palomares O, Polverino E, Sanchez-Garcia S, Sastre J, Schwarze J, Spanevello A, Ulrik CS, Usmani O, Van den Berge M, Vasakova M, Vijverberg S, Diamant Z.

Allergy. 2019 Apr 25. doi: 10.1111/all.13843. [Epub ahead of print] No abstract available.

PMID:
31021446
14.

Usability of mepolizumab single-use prefilled syringe for patient self-administration.

Bel EH, Bernstein DI, Bjermer L, Follows R, Bentley JH, Pouliquen I, Bradford E.

J Asthma. 2019 Apr 24:1-10. doi: 10.1080/02770903.2019.1604745. [Epub ahead of print]

PMID:
31017022
15.

The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option.

Bjermer L, Westman M, Holmström M, Wickman MC.

Allergy Asthma Clin Immunol. 2019 Apr 16;15:24. doi: 10.1186/s13223-018-0314-1. eCollection 2019. Review.

16.

The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies.

Campbell JD, Perry R, Papadopoulos NG, Krishnan J, Brusselle G, Chisholm A, Bjermer L, Thomas M, van Ganse E, van den Berge M, Quint J, Price D, Roche N.

Clin Transl Allergy. 2019 Mar 27;9:21. doi: 10.1186/s13601-019-0256-9. eCollection 2019.

17.

Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology Task Force.

Roche N, Campbell JD, Krishnan JA, Brusselle G, Chisholm A, Bjermer L, Thomas M, van Ganse E, van den Berge M, Christoff G, Quint J, Papadopoulos NG, Price D.

Clin Transl Allergy. 2019 Mar 27;9:20. doi: 10.1186/s13601-019-0255-x. eCollection 2019.

18.

Towards clinically applicable biomarkers for asthma - An EAACI position paper.

Diamant Z, Vijverberg S, Alving K, Bakirtas A, Bjermer L, Custovic A, Dahlen SE, Gaga M, Gerth van Wijk R, Del Giacco S, Hamelmann E, Heaney L, Heffler E, Kalayci Ö, Kostikas K, Lutter R, Olin AC, Sergejeva S, Simpson A, Sterk PJ, Tufvesson E, Agache I, Seys SF.

Allergy. 2019 Apr 6. doi: 10.1111/all.13806. [Epub ahead of print]

PMID:
30953574
19.

Expression, activity and localization of lysosomal sulfatases in Chronic Obstructive Pulmonary Disease.

Weidner J, Jogdand P, Jarenbäck L, Åberg I, Helihel D, Ankerst J, Westergren-Thorsson G, Bjermer L, Erjefält JS, Tufvesson E.

Sci Rep. 2019 Feb 13;9(1):1991. doi: 10.1038/s41598-018-37958-w.

20.

[The importance of selecting the right type of inhaler for patients with asthma and chronic obstructive pulmonary disease (COPD)].

Larsson K, Bjermer L, Svartengren M.

Lakartidningen. 2019 Feb 1;116. pii: FF76. Review. Swedish.

21.

Time to onset of improvements in Quality of Life from Temperature-controlled Laminar Airflow (TLA) in severe allergic asthma.

Bjermer L, Eriksson G, Radner F, Peterson S, Warner JO.

Respir Med. 2019 Feb;147:19-25. doi: 10.1016/j.rmed.2018.12.006. Epub 2018 Dec 28.

PMID:
30704694
22.

Effects of baseline symptom burden on treatment response in COPD.

Martinez FJ, Abrahams RA, Ferguson GT, Bjermer L, Grönke L, Voß F, Singh D.

Int J Chron Obstruct Pulmon Dis. 2019 Jan 4;14:181-194. doi: 10.2147/COPD.S179912. eCollection 2019.

23.

Much ado about Biologicals: Highlights of the Master Class on Biologicals, Prague, 2018.

Diamant Z, Vijverberg SJ, Agache I, Bjermer L, Chaker A, Gevaert P, Hellings PW, Nair P, O'Mahony L, Panzner P, Pohunek P, Vašáková M.

Allergy. 2019 Apr;74(4):837-840. doi: 10.1111/all.13688. Epub 2019 Jan 4. No abstract available.

PMID:
30506938
24.

Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current Insights.

Elieh Ali Komi D, Bjermer L.

Clin Rev Allergy Immunol. 2019 Apr;56(2):234-247. doi: 10.1007/s12016-018-8720-1. Review.

PMID:
30506113
25.

Distal respiratory tract viral infections in young children trigger a marked increase in alveolar mast cells.

Andersson CK, Shikhagaie M, Mori M, Al-Garawi A, Reed JL, Humbles AA, Welliver R, Mauad T, Bjermer L, Jordana M, Erjefält JS.

ERJ Open Res. 2018 Nov 23;4(4). pii: 00038-2018. doi: 10.1183/23120541.00038-2018. eCollection 2018 Oct.

26.

Targeting lipid mediators in asthma: time for reappraisal.

Diamant Z, Aalders W, Parulekar A, Bjermer L, Hanania NA.

Curr Opin Pulm Med. 2019 Jan;25(1):121-127. doi: 10.1097/MCP.0000000000000544.

PMID:
30422894
27.

Comparison of correct technique and preference for Spiromax®, Easyhaler® and Turbuhaler®: a single-site, single-visit, crossover study in inhaler-naïve adult volunteers.

Rönmark P, Jagorstrand B, Safioti G, Menon S, Bjermer L.

Eur Clin Respir J. 2018 Oct 22;5(1):1529536. doi: 10.1080/20018525.2018.1529536. eCollection 2018.

28.

Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK.

Voorham J, Roche N, Benhaddi H, van der Tol M, Carter V, van Boven JFM, Bjermer L, Miravitlles M, Price DB.

BMJ Open. 2018 Oct 27;8(10):e022051. doi: 10.1136/bmjopen-2018-022051. Erratum in: BMJ Open. 2018 Dec 9;8(12):e022051corr1. BMJ Open. 2019 Jun 14;9(6):e022051corr2.

29.

Osteopontin protects against pneumococcal infection in a murine model of allergic airway inflammation.

Kasetty G, Bhongir RKV, Papareddy P, Tufvesson E, Stenberg H, Bjermer L, Hultgårdh-Nilsson A, Herwald H, Egesten A.

Allergy. 2019 Apr;74(4):663-674. doi: 10.1111/all.13646. Epub 2018 Nov 19.

PMID:
30362569
30.

Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper.

Roth-Walter F, Adcock IM, Benito-Villalvilla C, Bianchini R, Bjermer L, Caramori G, Cari L, Chung KF, Diamant Z, Eguiluz-Gracia I, Knol EF, Kolios AGA, Levi-Schaffer F, Nocentini G, Palomares O, Puzzovio PG, Redegeld FA, van Esch BCAM, Stellato C.

Allergy. 2019 Mar;74(3):432-448. doi: 10.1111/all.13642. Epub 2019 Jan 8.

PMID:
30353939
31.

The Pulmonary Extracellular Matrix Is a Bactericidal Barrier Against Haemophilus influenzae in Chronic Obstructive Pulmonary Disease (COPD): Implications for an in vivo Innate Host Defense Function of Collagen VI.

Abdillahi SM, Tati R, Nordin SL, Baumgarten M, Hallgren O, Bjermer L, Erjefält J, Westergren-Thorsson G, Singh B, Riesbeck K, Mörgelin M.

Front Immunol. 2018 Aug 31;9:1988. doi: 10.3389/fimmu.2018.01988. eCollection 2018.

32.

Mast cells and mast cell tryptase enhance migration of human lung fibroblasts through protease-activated receptor 2.

Bagher M, Larsson-Callerfelt AK, Rosmark O, Hallgren O, Bjermer L, Westergren-Thorsson G.

Cell Commun Signal. 2018 Sep 15;16(1):59. doi: 10.1186/s12964-018-0269-3.

33.

The Efficiency Index (EFFi), based on volumetric capnography, may allow for simple diagnosis and grading of COPD.

Jarenbäck L, Tufvesson E, Ankerst J, Bjermer L, Jonson B.

Int J Chron Obstruct Pulmon Dis. 2018 Jun 27;13:2033-2039. doi: 10.2147/COPD.S161345. eCollection 2018.

34.

The neutrophil-mobilizing cytokine interleukin-26 in the airways of long-term tobacco smokers.

Che KF, Tufvesson E, Tengvall S, Lappi-Blanco E, Kaarteenaho R, Levänen B, Ekberg M, Brauner A, Wheelock ÅM, Bjermer L, Sköld CM, Lindén A.

Clin Sci (Lond). 2018 May 20;132(9):959-983. doi: 10.1042/CS20180057. Print 2018 May 23.

35.

Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe Asthma.

Papi A, Ryan D, Soriano JB, Chrystyn H, Bjermer L, Rodríguez-Roisin R, Dolovich MB, Harris M, Wood L, Batsiou M, Thornhill SI, Price DB.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):1989-1998.e3. doi: 10.1016/j.jaip.2018.03.008. Epub 2018 Apr 5.

PMID:
29627457
36.

Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults.

Porsbjerg C, Ulrik C, Skjold T, Backer V, Laerum B, Lehman S, Janson C, Sandstrøm T, Bjermer L, Dahlen B, Lundbäck B, Ludviksdottir D, Björnsdóttir U, Altraja A, Lehtimäki L, Kauppi P, Karjalainen J, Kankaanranta H.

Eur Clin Respir J. 2018 Mar 6;5(1):1440868. doi: 10.1080/20018525.2018.1440868. eCollection 2018. Review.

37.

Interferon-β deficiency at asthma exacerbation promotes MLKL mediated necroptosis.

Cerps SC, Menzel M, Mahmutovic Persson I, Bjermer L, Akbarshahi H, Uller L.

Sci Rep. 2018 Mar 9;8(1):4248. doi: 10.1038/s41598-018-22557-6.

38.

Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.

Åhrman E, Hallgren O, Malmström L, Hedström U, Malmström A, Bjermer L, Zhou XH, Westergren-Thorsson G, Malmström J.

J Proteomics. 2018 Oct 30;189:23-33. doi: 10.1016/j.jprot.2018.02.027. Epub 2018 Mar 1.

PMID:
29501846
39.

Endoplasmic reticulum, Golgi, and lysosomes are disorganized in lung fibroblasts from chronic obstructive pulmonary disease patients.

Weidner J, Jarenbäck L, Åberg I, Westergren-Thorsson G, Ankerst J, Bjermer L, Tufvesson E.

Physiol Rep. 2018 Mar;6(5). doi: 10.14814/phy2.13584.

40.

Chronic obstructive pulmonary disease guidelines in Europe: a look into the future.

Miravitlles M, Roche N, Cardoso J, Halpin D, Aisanov Z, Kankaanranta H, Kobližek V, Śliwiński P, Bjermer L, Tamm M, Blasi F, Vogelmeier CF.

Respir Res. 2018 Jan 18;19(1):11. doi: 10.1186/s12931-018-0715-1. Review.

41.

Uncontrolled asthmatics have increased FceRI+ and TGF-β-positive MCTC mast cells and collagen VI in the alveolar parenchyma.

Andersson CK, Weitoft M, Rydell-Törmänen K, Bjermer L, Westergren-Thorsson G, Erjefält JS.

Clin Exp Allergy. 2018 Mar;48(3):266-277. doi: 10.1111/cea.13092. Epub 2018 Feb 15.

PMID:
29336501
42.

House dust mite impairs antiviral response in asthma exacerbation models through its effects on TLR3.

Akbarshahi H, Menzel M, Ramu S, Mahmutovic Persson I, Bjermer L, Uller L.

Allergy. 2018 May;73(5):1053-1063. doi: 10.1111/all.13378. Epub 2018 Feb 5.

PMID:
29319193
43.

Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population.

Bjermer L, van Boven JFM, Costa-Scharplatz M, Keininger DL, Gutzwiller FS, Lisspers K, Mahon R, Olsson P, Roche N.

Respir Res. 2017 Dec 11;18(1):206. doi: 10.1186/s12931-017-0688-5.

44.

Allergens produce serine proteases-dependent distinct release of metabolite DAMPs in human bronchial epithelial cells.

Ramu S, Menzel M, Bjermer L, Andersson C, Akbarshahi H, Uller L.

Clin Exp Allergy. 2018 Feb;48(2):156-166. doi: 10.1111/cea.13071. Epub 2017 Dec 28.

PMID:
29210131
45.

Caspase-1 deficiency reduces eosinophilia and interleukin-33 in an asthma exacerbation model.

Menzel M, Akbarshahi H, Mahmutovic Persson I, Puthia M, Bjermer L, Uller L.

ERJ Open Res. 2017 Oct 16;3(4). pii: 00047-2017. doi: 10.1183/23120541.00047-2017. eCollection 2017 Oct.

46.

Lung function after extremely preterm birth-A population-based cohort study (EXPRESS).

Thunqvist P, Tufvesson E, Bjermer L, Winberg A, Fellman V, Domellöf M, Melén E, Norman M, Hallberg J.

Pediatr Pulmonol. 2018 Jan;53(1):64-72. doi: 10.1002/ppul.23919. Epub 2017 Nov 20.

PMID:
29152899
47.

Inflammation and chronic colonization of Haemophilus influenzae in sputum in COPD patients related to the degree of emphysema and bronchiectasis in high-resolution computed tomography.

Tufvesson E, Markstad H, Bozovic G, Ekberg M, Bjermer L.

Int J Chron Obstruct Pulmon Dis. 2017 Nov 1;12:3211-3219. doi: 10.2147/COPD.S137578. eCollection 2017.

48.

Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma.

Murphy K, Jacobs J, Bjermer L, Fahrenholz JM, Shalit Y, Garin M, Zangrilli J, Castro M.

J Allergy Clin Immunol Pract. 2017 Nov - Dec;5(6):1572-1581.e3. doi: 10.1016/j.jaip.2017.08.024. Erratum in: J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):1095.

49.

CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report.

Bousquet J, Onorato GL, Bachert C, Barbolini M, Bedbrook A, Bjermer L, de Sousa JC, Chavannes NH, Cruz AA, De Manuel Keenoy E, Devillier P, Fonseca J, Hun S, Kostka T, Hellings PW, Illario M, Ivancevich JC, Larenas-Linnemann D, Millot-Keurinck J, Ryan D, Samolinski B, Sheikh A, Yorgancioglu A, Agache I, Arnavielhe S, Bewick M, Annesi-Maesano I, Anto JM, Bergmann KC, Bindslev-Jensen C, Bosnic-Anticevich S, Bouchard J, Caimmi DP, Camargos P, Canonica GW, Cardona V, Carriazo AM, Cingi C, Colgan E, Custovic A, Dahl R, Demoly P, De Vries G, Fokkens WJ, Fontaine JF, Gemicioğlu B, Guldemond N, Gutter Z, Haahtela T, Hellqvist-Dahl B, Jares E, Joos G, Just J, Khaltaev N, Keil T, Klimek L, Kowalski ML, Kull I, Kuna P, Kvedariene V, Laune D, Louis R, Magnan A, Malva J, Mathieu-Dupas E, Melén E, Menditto E, Morais-Almeida M, Mösges R, Mullol J, Murray R, Neffen H, O'Hehir R, Palkonen S, Papadopoulos NG, Passalacqua G, Pépin JL, Portejoie F, Price D, Pugin B, Raciborski F, Simons FER, Sova M, Spranger O, Stellato C, Todo Bom A, Tomazic PV, Triggiani M, Valero A, Valovirta E, VandenPlas O, Valiulis A, van Eerd M, Ventura MT, Wickman M, Young I, Zuberbier T, Zurkuhlen A, Senn A.

Clin Transl Allergy. 2017 Oct 23;7:37. doi: 10.1186/s13601-017-0173-8. eCollection 2017. Review.

50.

Asthma symptoms, mannitol reactivity and exercise-induced bronchoconstriction in adolescent swimmers versus tennis players.

Romberg K, Tufvesson E, Bjermer L.

J Asthma Allergy. 2017 Oct 3;10:249-260. doi: 10.2147/JAA.S134794. eCollection 2017.

Supplemental Content

Loading ...
Support Center